ClinicalTrials.gg
RecruitingNCT07512999Updated Nov 4, 2026

The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test

An interventional study of Virtual Reality and Nature sounds in Pregnancy - Prenatal Testing, sponsored by Amasya University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-04.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Amasya University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Nov 4, 2026Now RecruitingFirst site in Turkey (Türkiye)+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The aim of this study is to examine the effect of using nature sounds and virtual reality during the non-stress test on fetal well-being, maternal anxiety, comfort, and satisfaction. The study sample will consist of all pregnant women admitted to the Non-Stress Test (NST) unit. A total of 150 women will be included in the sample: 50 for the virtual reality group, 50 for the nature sounds group, and 50 for the control group.

Read the detailed description

Pregnancy is a multidimensional process characterized not only by physiological changes but also by the restructuring of social roles and psychological adaptation. The changes that occur during this process affect both the mother and the fetus. Increased maternal stress and anxiety may influence fetal development through hormonal mechanisms. Therefore, regular and holistic monitoring of pregnancy is important. Antenatal care is a systematic evaluation process aimed at protecting maternal and fetal health and identifying risk factors. One of the frequently used non-invasive methods for assessing fetal health is the non-stress test. It is widely used because it is easy to administer and considered safe. The test evaluates the relationship between fetal heart rate, fetal movements, and uterine contractions. A reactive result indicates that the fetus is in good condition, whereas a non-reactive result may require further evaluation. Although the non-stress test is non-invasive and painless, it generally lasts at least 20 minutes, and remaining in the same position may lead to hypotension, discomfort, and anxiety. Increased maternal anxiety may affect fetal heart rate patterns, increase false-positive rates, and result in unnecessary interventions. Therefore, non-pharmacological interventions aimed at increasing maternal comfort and reducing anxiety during the NST process are important. Nature sounds may reduce perceived stress by promoting relaxation, while virtual reality may decrease anxiety and increase satisfaction by diverting attention away from the environment. The aim of this study is to determine the effects of using nature sounds and virtual reality during the non-stress test on fetal well-being, maternal anxiety, comfort, and satisfaction. The study sample will consist of all pregnant women admitted to the Non-Stress Test (NST) unit. A total of 150 women will be included in the sample: 50 for the virtual reality group, 50 for the nature sounds group, and 50 for the control group. Personal Information Form, Non Stress Test Evaluation Form, Visual Analog Scale for Satisfaction (VAS-Satisfaction), Visual Analog Scale for Comfort (VAS-Comfort), Spielberger State-Trait Anxiety Inventory (STAI) Scale, Intervention for the experimental group, the Evaluation Form (Virtual reality, Nature sounds) will be used in data collection.

02

Conditions studied

  • Pregnancy - Prenatal Testing

Browse trials for

Keywords

  • Non-Stress Test
  • Pregnancy
  • Anxiety
  • Fetal health
03

In context

Anxiety Disorders Unverified

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

This study's planned enrollment of 150 is above the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Amasya University is the lead sponsor of 81 studies on the registry; 23 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older
  • Being at 32 weeks of gestation or beyond
  • Having a healthy pregnancy
  • Having a singleton and viable pregnancy
  • Not using tobacco or alcohol
  • Having eaten at least two hours before the NST procedure

Exclusion criteria

Exclusion Criteria:

  • Having any communication impairment (language, vision, hearing, speech, etc.)
  • Having a physical or cognitive condition that prevents the use of the virtual reality application and nature sound Having a diagnosis of a high-risk pregnancy Having a diagnosis of a significant chronic (cardiac, renal, neurological, etc.) or psychiatric disorder (psychosis, neurosis, substance dependence, etc.) Having a multiple pregnancy Having a fetus with an anomaly Experiencing fetal distress requiring emergency intervention Having uterine contractions
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Virtual reality group

    After obtaining written informed consent from the women, data collection forms will be administered (Personal Information Form, Spielberger State-Trait Anxiety Inventory-STAI). This group will include 50 pregnant women. Following the administration of the survey form, the virtual reality headset will be introduced. The headset will be fitted before the procedure begins, and women will be instructed on how to continue watching the video while wearing the headset during the procedure. Women treated with virtual reality will be presented with videos of natural scenes (forest and sea) accompanied by nature sounds and asked to watch. After the procedure is complete, final tests will be conducted: Non-Stress Test Evaluation Form, Visual Analog Scale for Satisfaction (VAS-Satisfaction), Visual Analog Scale for Comfort (VAS-Comfort), Spielberger State-Trait Anxiety Inventory (STAI) Scale, Intervention for the experimental group, and the Evaluation Form (virtual reality, nature sounds).

    Behavioral: Virtual Reality

  • Experimental
    Nature sounds group

    After obtaining written informed consent from the women, data collection forms will be administered (Personal Information Form, Spielberger State-Trait Anxiety Inventory-STAI). This group will include 50 pregnant women. Women in the nature sounds group will be provided with the opportunity to listen to relaxing nature sounds (sea, rain, wind, river, birds) using MP3 players and headphones, according to their preferences. After the procedure is complete, final tests will be conducted: Non-Stress Test Evaluation Form, Visual Analog Scale for Satisfaction (VAS-Satisfaction), Visual Analog Scale for Comfort (VAS-Comfort), Spielberger State-Trait Anxiety Inventory (STAI) Scale, Intervention for the experimental group, and the Evaluation Form (virtual reality, nature sounds).

    Behavioral: Nature sounds

  • Experimental
    Control group

    After obtaining written informed consent from the women, data collection forms will be administered (Personal Information Form, Spielberger State-Trait Anxiety Inventory-STAI). This group will include 50 pregnant women. Women in the control group will not receive any intervention. After the non-stress test is complete, final tests will be conducted: Non-Stress Test Evaluation Form, Visual Analog Scale for Satisfaction (VAS-Satisfaction), Visual Analog Scale for Comfort (VAS-Comfort), Spielberger State-Trait Anxiety Inventory (STAI) Scale, Intervention for the experimental group, and the Evaluation Form (virtual reality, nature sounds).

    Behavioral: Control

Interventions

  • BehavioralVirtual Reality

    Women treated with virtual reality will be presented with videos of natural scenes (forest and sea) accompanied by nature sounds and asked to watch. The headset will be fitted before the procedure begins, and women will be instructed on how to continue watching the video while wearing the headset during the procedure.

  • BehavioralNature sounds

    Women in the nature sounds group will be given the opportunity to listen to relaxing nature sounds (sea, rain, wind, river, birds) using MP3 players and headphones according to their preferences throughout the non-stress test.

  • BehavioralControl

    Participants in the control group received standard care (verbal information about procedure and a short written information about the procedure) and no intervention will perform.

06

What researchers measure

Primary outcomes

  1. State-Trait Anxiety Inventory (STAI) Scale

    The inventory was developed by Spielberger, Gorsuch, and Lushene in 1970. An adaptation, validity, and reliability study of the State-Trait Anxiety Scale in Turkish was conducted by Oner and Le Compte in 1983. The scale consists of two subdimensions: the state anxiety has 20 items and is used to determine what is felt at a specific moment under certain conditions, and the trait anxiety has 20 items and is used to determine what has been felt in the last 7 days. High scores from each subscale indicate a high level of anxiety. The Cronbach's a for the STAI ranges from 0.83 to 0.87

    Time frame: Before the non-stress test and after the procedure is completed (20 minutes after the start of the procedure)

  2. Visual Analog Scale for Comfort (VAS-Comfort)

    The Visual Analog Scale (VAS) will be used to determine the comfort levels of the participants. Developed by Price et al. in 1983 for the purpose of evaluating subjective pain, the VAS is an easy-to-apply measurement method whose validity and reliability are accepted in the international literature (Price et al., 1987; Akbay, 2026). Based on the individual's subjective evaluation, the VAS is used not only to determine the level of pain but also to evaluate subjective conditions such as fatigue and discomfort. The Visual Analog Scale (VAS) is a 10 cm long scale that can be arranged vertically or horizontally, with endpoints defined by different expressions. In this study, to evaluate the comfort levels of individuals, the leftmost end of the scale will be defined as "0 = Not comfortable at all" and the rightmost end as "10 = Very comfortable". To make the scale more understandable and applicable, vertical lines and numerical values will be used on the horizontal line.

    Time frame: After the non-stress test is completed (20 minutes after the start of the procedure)

  3. Visual Analog Scale for Satisfaction (VAS-Satisfaction)

    The VAS satisfaction form will be used to determine the satisfaction levels of the participants. The Visual Analog Scale (VAS) is a reliable and easily applicable measurement method with endpoints defined by different expressions, and is 10 cm long. VAS is also used to evaluate subjective states such as satisfaction. In this study, to evaluate the satisfaction levels of individuals, the leftmost end of the scale will be defined as "0 = Not satisfied at all" and the rightmost end as "10 = Very satisfied". In order to make the scale more understandable and applicable, vertical lines and numerical values will be used on the horizontal line.

    Time frame: After the non-stress test is completed (20 minutes after the start of the procedure)

  4. Non Stress Test Evaluation Form

    The NST Evaluation Form will be used to determine the emotional state of participants during the NST procedure and to evaluate the results of the non-stress test (NST). The form includes variables such as NST recording time, basal fetal heart rate (FHR), presence and number of accelerations and decelerations, and whether it is evaluated as reactive or non-reactive. The National Institute of Child Health and Human Development 2008 guidelines will be used to evaluate the NST results.

    Time frame: After the non-stress test is completed (20 minutes after the start of the procedure)

  5. Intervention for the experimental group The Evaluation Form (Virtual reality, Nature sounds)

    In this study, an intervention evaluation form prepared by the researcher will be used for the virtual reality and nature sounds groups. Separate intervention evaluation forms will be used for the nature sounds and virtual reality groups. The form includes questions about the participants' emotional state during the intervention, whether they would like to use it again, and whether they would recommend the application to other pregnant women.

    Time frame: After the non-stress test is completed (20 minutes after the start of the procedure)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Mar 2027, 8 months after the start.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 8 months is below that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2026
First posted
Apr 6, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Mar 1, 2027
CompletionEst.
Mar 31, 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Amasya University Sabuncuoğlu Şerefeddin Training and Research Hospital, Amasya · Amasya, Turkey (Türkiye)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Amasya University Sabuncuoğlu Şerefeddin Training and Research Hospital, Amasya · Amasya, Turkey (Türkiye)
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07512999
Lead sponsor
Amasya University
Responsible party
Sponsor
First posted
Apr 6, 2026
Start date
Jul 1, 2026
Primary completion
Mar 1, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Elif KETEN EDİS, Assoc.Prof, PhD
Contact
elifketen05@gmail.com
+90 358 211 50 05 ext. 4802
Sevgi ARSLAN, BSc, RN
Contact
sevgiedaarslan@gmail.com
+90 358 211 50 05
Elif Keten Edis, PhD
study director · Amasya University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion